Adiponectin signals its biological effects primarily by binding two distinct transmembrane receptors, adiponectin receptors 1and 2, which are down-regulated as is adiponectin in obesity, obesity-linked insulin resistance, and type 2 diabetes mellitus [18]–[21]. Here, ADIPOQ is linked to obesity disorder.